News Detail
New Delhi, 5 March 2024: The Delhi High Court has barred Natco Pharma from manufacturing and selling cancer drug Olaparib either under the brand name ‘BRACANAT’ or under other brand names till further orders.
“…the defendant (Natco) is in fact ......
View Details
Source : DrugsControl Media Services
Natco Pharma
natco pharma
Delhi
Delhi High Court
cancer drug
Olaparib
BRACANAT
brand names
Patents Act
infringement
Related News
- PIL questioning quality of Anti-Rabies Vaccine disposed of by SC (22-01-2025)
- NCB seizes drugs worth more than 14 lakhs in Jaipur, One arrested (21-01-2025)
- Trump withdraws US from WHO (21-01-2025)
- Telangana Officials Raid Illegal De-Addiction Center in Hanumakonda (21-01-2025)
- Major pharmacy benefit managers found by US FTC to have inflated drug prices for a $7.3 billion gain (21-01-2025)
- Agra: Child given expired vaccine, doctor said- a mistake happened (21-01-2025)
- Police Seize Nearly 1,300 Bottles of Codeine Cough Syrup in Abandoned Vehicle (21-01-2025)
- Vaccine sector does not require incentives or breaks but needs relief from rigid price controls: Adar Poonawalla (21-01-2025)
- CSIR-IIIM Hosts Groundbreaking Workshop on Herbal Medicine Production (21-01-2025)
- 530 Sedative Pills seized from Nalagarh resident (21-01-2025)